Neurosense Therapeutics Ltd's ROI from its fourth quarter of 2025 to the fourth quarter of 2023 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Neurosense Therapeutics Ltd's ROI in the fourth quarter of 2025?
Due to the stockholders deficit and subsequent negative measured investments, it was not possible to calculate Neurosense Therapeutics Ltd's return on investment (ROI) in its fourth quarter of 2025

Definition and Formula of Return on Investment

Select the Comparisons :

None ▼

Select the Ratio:

Return on Investment ROI▼

None ▼

Return on Investment ROI▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Investment	(Dec 31 2025) IV. Quarter	0 III. Quarter	0 II. Quarter	0 I. Quarter	(Dec 31 2023) IV. Quarter
Y / Y Investment Change TTM	-	-90.14 %	-	-	-97.35 %
Y / Y Net Income Change TTM	-	-	-	-	-
Investment (TTM) in Millions	0	-2	1	-2	3
Return On Investment (TTM)	-	-	-0 %	-	-5440.99 %
NRSN's Overall Ranking	#	#	#	#	#
Seq. Investment Change TTM	-	-	-	-	-34.73 %
Seq. Net Income Change TTM	-	-	-	-	-
Net Income (TTM) in Millions	-11	0	0	-7	-7

NRSN Company Profile >> Back to NRSN Roi Comparisons >> See Annual NRSN Return On Investment

Return On Investment NRSN's Ranking
Within:	No.
Industry	#
Sector	#
Overall	#

Return On Investment Statistics
High	Average	Low
0 %	0 %	0 %

Financial Statements
Neurosense Therapeutics Ltd's IV. Quarter Investments	$ 0 Millions	NRSN's Balance sheet
Neurosense Therapeutics Ltd's IV. Quarter Income	$ -11 Millions	Quarterly NRSN's Income Statement
NRSN's Income by Division		See NRSN's Income by Division

NRSN Annual Return On Investment	(Dec 31 2025) 2025	(Dec 31 2024) 2024	(Dec 31 2023) 2023	(Dec 31 2022) 2022	(Dec 31 2020) 2021
Total Investments in Millions	-2	3	0	6	13
Y / Y Investment Growth	-	-	-	-50.96 %	-
Net Income in Millions	-11	-10	-11	-12	-4
Y / Y Net Income Growth	-	-	-	-	-
Annual Return On Investment	-	-392.39 %	-	-198.74 %	-31.91 %

Annual Roi Comment

Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
NRSN's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for NRSN's Competitors
Subscribers only: Roi for Neurosense Therapeutics Ltd's Suppliers
Subscribers only: Return On Investment for NRSN's Customers

Other Ratios
NRSN's Roa	NRSN's Inventory Turnover Ratio	NRSN's Growth Rates	NRSN's Dividend Statistics
	NRSN's Profitability Ratios	NRSN's Asset Turnover Ratio	NRSN's Dividend Growth
NRSN's Roe	NRSN's Valuation Ratios	NRSN's Financial Strength Ratios	NRSN's Dividend Payout Ratio

Companies with similar Return On Investment at Dec 31 2025, within Healthcare Sector	ROI
Galera Therapeutics Inc	1,996.51 %
Capsovision Inc	865.95 %
Glucotrack Inc	372.04 %
Elutia Inc	358.27 %

Date modified: 2026-09-14T21:17:17+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.